The cost-effectiveness of CAR T-cell therapy

Prophylactic tocilizumab prior to infusion of anti-CD19 CAR-T ce may reduce toxicity in older ly...Подробнее

Prophylactic tocilizumab prior to infusion of anti-CD19 CAR-T ce may reduce toxicity in older ly...

Understanding CAR T Cell Therapy in India: Cost and Treatment BenefitsПодробнее

Understanding CAR T Cell Therapy in India: Cost and Treatment Benefits

T Cell Expansion in ImmunotherapyПодробнее

T Cell Expansion in Immunotherapy

Dr. Colleen Delaney from Coeptis Therapeutics on the development of next-generation cell therapy ...Подробнее

Dr. Colleen Delaney from Coeptis Therapeutics on the development of next-generation cell therapy ...

India Has Low-Cost CAR T-Cell Therapy: Can US Follow Suit?Подробнее

India Has Low-Cost CAR T-Cell Therapy: Can US Follow Suit?

Papers Unplugged: Is CAR-T Economically Sustainable?Подробнее

Papers Unplugged: Is CAR-T Economically Sustainable?

The value of axi-cel as a second-line treatment in R/R LBCLПодробнее

The value of axi-cel as a second-line treatment in R/R LBCL

CAR T Cell Therapy for CancerПодробнее

CAR T Cell Therapy for Cancer

Revolutionizing Cancer Care: Affordable CAR-T Therapy by IIT Bombay | NeosciencehubПодробнее

Revolutionizing Cancer Care: Affordable CAR-T Therapy by IIT Bombay | Neosciencehub

Dr. Colleen Delaney from Coeptis on the development of next-generation cell therapies for cancerПодробнее

Dr. Colleen Delaney from Coeptis on the development of next-generation cell therapies for cancer

CAR-T cost effectiveness study | Dana-Farber Cancer InstituteПодробнее

CAR-T cost effectiveness study | Dana-Farber Cancer Institute

06 Memory-rich CAR-T cell engineering by piggyBac transposon system for solid malignanciesПодробнее

06 Memory-rich CAR-T cell engineering by piggyBac transposon system for solid malignancies

Progress Report IV - Ádám SzilágyiПодробнее

Progress Report IV - Ádám Szilágyi

Low-Cost CAR-T Cell Therapy For Blood Cancer Treatment in India:At a Fraction Of Global Prices |N18VПодробнее

Low-Cost CAR-T Cell Therapy For Blood Cancer Treatment in India:At a Fraction Of Global Prices |N18V

Progress Report III - Ádám SzilágyiПодробнее

Progress Report III - Ádám Szilágyi

Strategies to improve cost & access to CAR-T therapyПодробнее

Strategies to improve cost & access to CAR-T therapy

Cost-effectiveness analysis of CAR-T therapyПодробнее

Cost-effectiveness analysis of CAR-T therapy

Evaluating the cost and benefits of CAR-T therapyПодробнее

Evaluating the cost and benefits of CAR-T therapy

CAR-T Revolution: Unleashing the Immune Power Against CancerПодробнее

CAR-T Revolution: Unleashing the Immune Power Against Cancer

Assessing the cost-effectiveness of CAR-T therapy in adult patients with R/R ALLПодробнее

Assessing the cost-effectiveness of CAR-T therapy in adult patients with R/R ALL

Популярное